{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:51:44Z","timestamp":1774569104740,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In recent years a growing number of manufacturers and medical abortion products have entered country markets and health systems, with varying degrees of quality and accessibility. An interplay of factors including pharmaceutical regulations, abortion laws, government policies and service delivery guidelines and provider\u2019s knowledge and practices influence the availability of medical abortion medicines. We assessed the availability of medical abortion in eight countries to increase understanding among policymakers of the need to improve availability and affordability of quality-assured medical abortion products at regional and national levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using a national assessment protocol and an availability framework, we assessed the availability of medical abortion medicines in Bangladesh, Liberia, Malawi, Nepal, Nigeria, Rwanda, Sierra Leone and South Africa between September 2019 and January 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Registration of abortion medicines\u2014misoprostol or a combination of mifepristone and misoprostol\u2014was established in all countries assessed, except Rwanda. Mifepristone and misoprostol regimen for medical abortion was identified on the national essential medicines list\/standard treatment guidelines for South Africa as well as in specific abortion care service and delivery guidelines for Bangladesh, Nepal, Nigeria, and Rwanda. In Liberia, Malawi, and Sierra Leone\u2014countries with highly restrictive abortion laws and no abortion service delivery guidelines or training curricula\u2014no government-supported training on medical abortion for public sector providers had occurred. Instead, training on medical abortion was either limited in scope to select private sector providers and pharmacists or prohibited. Community awareness activities on medical abortion have been limited in scope across the countries assessed and where abortion is broadly legal, most women do not know that it is an option.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Understanding the factors that influence the availability of medical abortion medicines is important to support policymakers improve availability of these medicines. The landscape assessments documented that medical abortion commodities can be uniquely impacted by the laws, policies, values, and degree of restrictions placed on service delivery programs. Results of the assessments can guide actions to improve access.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12978-023-01574-3","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T15:03:53Z","timestamp":1681225433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities"],"prefix":"10.1186","volume":"20","author":[{"given":"Amy","family":"Grossman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndola","family":"Prata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela","family":"Ganatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Lavelanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"L\u00e4ser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chilanga","family":"Asmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayfa","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopold","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Mahmudur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musu Julie","family":"Conneh-Duworko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bentoe Zoogley","family":"Tehoungue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"Chanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan Prasad","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olumuyiwa Adesanya","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayode","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theopista John","family":"Kabuteni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binyam Getachew","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Moses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sithembile","family":"Dlamini-Nqeketo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thembi","family":"Zulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrika","family":"Rehnstr\u00f6m Loi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"10110","key":"1574_CR1","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/S0140-6736(17)31794-4","volume":"390","author":"B Ganatra","year":"2017","unstructured":"Ganatra B, Gerdts C, Rossier C, Johnson BR, Tun\u00e7alp \u00d6, Assifi A, et al. Global, regional, and subregional classification of abortions by safety, 2010\u201314: estimates from a Bayesian hierarchical model. Lancet. 2017;390(10110):2372\u201381.","journal-title":"Lancet"},{"key":"1574_CR2","unstructured":"WHO. Abortion care guideline. Geneva: World Health Organization; 2022. License: CC\u00a0BY-NC-SA\u00a03.0\u00a0IGO [Report]. https:\/\/apps.who.int\/iris\/handle\/10665\/349316. Accessed 5 Aug 2022."},{"issue":"Suppl 1","key":"1574_CR3","first-page":"S16","volume":"121","author":"KR Culwell","year":"2013","unstructured":"Culwell KR, Hurwitz M. Addressing barriers to safe abortion. Int J Gynaecol Obstet. 2013;121(Suppl 1):S16\u20139.","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"1574_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237227","volume":"15","author":"SR Lattof","year":"2020","unstructured":"Lattof SR, Coast E, Rodgers YVM, Moore B, Poss C. The mesoeconomics of abortion: a scoping review and analysis of the economic effects of abortion on health systems. PLoS ONE. 2020;15(11): e0237227.","journal-title":"PLoS ONE"},{"issue":"3","key":"1574_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1363\/3816412","volume":"38","author":"B Winikoff","year":"2012","unstructured":"Winikoff B, Sheldon W. Use of medicines changing the face of abortion. Int Perspect Sex Reprod Health. 2012;38(3):164\u20136.","journal-title":"Int Perspect Sex Reprod Health"},{"issue":"3","key":"1574_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jfprhc-2014-100990","volume":"41","author":"P Harvey","year":"2015","unstructured":"Harvey P. Medical abortion: the hidden revolution. J Fam Plann Reprod Health Care. 2015;41(3):193\u20136.","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"1574_CR7","first-page":"1982460","volume":"29","author":"J Durocher","year":"2021","unstructured":"Durocher J, Kilfedder C, Frye LJ, Winikoff B, Srinivasan K. A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally. Sex Reprod Health Matters. 2021;29(1):1982460.","journal-title":"Sex Reprod Health Matters"},{"issue":"2","key":"1574_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijgo.2008.12.016","volume":"105","author":"MM Fernandez","year":"2009","unstructured":"Fernandez MM, Coeytaux F, de Leon RG, Harrison DL. Assessing the global availability of misoprostol. Int J Gynaecol Obstet. 2009;105(2):180\u20136.","journal-title":"Int J Gynaecol Obstet"},{"key":"1574_CR9","unstructured":"Gynuity Health Projects. Map of mifepristone approvals. https:\/\/gynuity.org\/assets\/resources\/mapmife-en.pdf. Accessed 9 Jun 2022."},{"key":"1574_CR10","unstructured":"Gynuity Health Projects. Map of misoprostol approvals; https:\/\/gynuity.org\/assets\/resources\/mapmiso__en.pdf. Accessed 9 Jun 2022."},{"issue":"Suppl 1","key":"1574_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12978-022-01530-7","volume":"20","author":"U Rehnstr\u00f6m Loi","year":"2023","unstructured":"Rehnstr\u00f6m Loi U, Prata N, Grossman A, Lavelanet A, Williams N, Ganatra B. In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments. Reprod Health. 2023;20(Suppl 1):20. https:\/\/doi.org\/10.1186\/s12978-022-01530-7.","journal-title":"Reprod Health"},{"key":"1574_CR12","unstructured":"WHO, 2020. Selection of essential medicines at country level: using the WHO Model List of Essential Medicines to update a national essential medicines list. Geneva: World Health Organization; 2020. License: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/news\/item\/30-03-2020-new-who-guide-to-help-countries-expand-access-to-essential-medicines. Accessed 9 Jun 2022."},{"key":"1574_CR13","volume-title":"Standard treatment guidelines and essential medicines list for South Africa: hospital level, adult","author":"Republic of South Africa","year":"2019","unstructured":"Republic of South Africa. Standard treatment guidelines and essential medicines list for South Africa: hospital level, adult. 5th ed. Pretoria: National Department of Health; 2019.","edition":"5"},{"key":"1574_CR14","unstructured":"Government of Bangladesh. Bangladesh National Service Delivery Guideline on Menstrual Regulation with Medication. Dhaka: Ministry of Health and Family Welfare; 2015. https:\/\/abortion-policies.srhr.org\/documents\/countries\/06-BANGLADESH-NATIONAL-SERVICE-DELIVERY-GUIDELINE-ON-MENSTRUAL-REGULATION-WITH-MEDICATION.pdf. Accessed 5 Mar 2022."},{"key":"1574_CR15","volume-title":"Safe abortion service programme procedure guideline","author":"Government of Nepal","year":"2016","unstructured":"Government of Nepal. Safe abortion service programme procedure guideline. 2nd ed. Kathmandu: Ministry of Health and Social Welfare, Family Health Division; 2016.","edition":"2"},{"key":"1574_CR16","volume-title":"National guidelines on safe termination of pregnancy for Legal Indications","author":"Government of Nigeria","year":"2018","unstructured":"Government of Nigeria. National guidelines on safe termination of pregnancy for Legal Indications. Abuja: Federal Ministry of Health; 2018."},{"key":"1574_CR17","unstructured":"Government of Rwanda. National Protocol for the Operationalization of Exemptions for Abortion in the Law, 2018. http:\/\/bixby.berkeley.edu\/wp-content\/uploads\/2015\/03\/VSI_Rwanda-MOH-Operationalization-of-Exemptions-for-Abortion-Brief-2015-03-17F.pdf. Accessed 10 Aug 2022."},{"key":"1574_CR18","volume-title":"Nigeria essential medicines list","author":"Government of Nigeria","year":"2020","unstructured":"Government of Nigeria. Nigeria essential medicines list. 7th ed. Abuja: Federal Ministry of Health; 2020.","edition":"7"},{"issue":"1","key":"1574_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.29063\/ajrh2017\/v21i1.7","volume":"21","author":"NN Sahin Hodoglugil","year":"2017","unstructured":"Sahin Hodoglugil NN, Ngabo F, Ortega J, Ngoga E, Dushimeyezu E, Kanyamanza E, et al. Making abortion safer in Rwanda: operationalization of the penal code of 2012 to expand legal exemptions and challenges. Afr J Reprod Health. 2017;21(1):82.","journal-title":"Afr J Reprod Health"},{"key":"1574_CR20","unstructured":"National Institute of Population Research and Training (NIPORT), Mitra and Associates, ICF International.\u00a0Bangladesh demographic and health survey, 2014.\u00a0Dhaka and Calverton: NIPORT, Mitra & Associates and ICF International; 2014. [Report] https:\/\/dhsprogram.com\/pubs\/pdf\/FR311\/FR311.pdf. Accessed 1 Mar 2021."},{"key":"1574_CR21","unstructured":"Ministry of Health, Nepal, New ERA, and ICF. Nepal Demographic and Health Survey 2016. Kathmandu: Ministry of Health, Nepal, New ERA, and ICF; 2017. [Report] https:\/\/www.dhsprogram.com\/pubs\/pdf\/fr336\/fr336.pdf. Accessed 28 Jul 2022."},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-4755-3-7","volume":"3","author":"C Morroni","year":"2006","unstructured":"Morroni C, Myer L, Tibazarwa K. Knowledge of the abortion legislation among South African women: a cross-sectional study. Reprod Health. 2006;3:7.","journal-title":"Reprod Health"},{"issue":"2","key":"1574_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.contraception.2017.11.006","volume":"97","author":"FA Huda","year":"2018","unstructured":"Huda FA, Mahmood HR, Alam A, Ahmmed F, Karim F, Sarker BK, et al. Provision of menstrual regulation with medication among pharmacies in three municipal districts of Bangladesh: a situation analysis. Contraception. 2018;97(2):144\u201351.","journal-title":"Contraception"},{"issue":"44 Suppl 1","key":"1574_CR24","first-page":"104","volume":"22","author":"A Tamang","year":"2015","unstructured":"Tamang A, Puri M, Lama K, Shrestha P. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion. Reprod Health Matters. 2015;22(44 Suppl 1):104\u201315.","journal-title":"Reprod Health Matters"},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12978-015-0014-y","volume":"12","author":"J Harries","year":"2015","unstructured":"Harries J, Gerdts C, Momberg M, Greene FD. An exploratory study of what happens to women who are denied abortions in Cape Town, South Africa. Reprod Health. 2015;12:21.","journal-title":"Reprod Health"},{"key":"1574_CR26","unstructured":"Bower J, Romero M, Chinery L. (2021) Market Assessment for Medical Abortion in Argentina [Report]. https:\/\/www.rhsupplies.org\/uploads\/tx_rhscpublications\/Market_Assessment_for_Medical_Abortion_Drugs_in_Argentina.pdf. Accessed 5 Mar 2021."},{"key":"1574_CR27","unstructured":"Mann Global Health. Landscape Assessment: Leveraging the role of national distributors to increase access to MA combi-packs in Africa. January 2019 [Report]. https:\/\/www.rhsupplies.org\/uploads\/tx_rhscpublications\/Landscape_Assessment_Combi-Packs_RHSC_01.pdf. Accessed 20 Aug 2022."},{"key":"1574_CR28","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) [Internet]. www.ich.org\/page\/ctd. Accessed 24 Aug 2022."},{"issue":"1","key":"1574_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12913-016-1946-9","volume":"17","author":"VA Perumal-Pillay","year":"2017","unstructured":"Perumal-Pillay VA, Suleman F. Selection of essential medicines for South Africa\u2014an analysis of in-depth interviews with national essential medicines list committee members. BMC Health Serv Res. 2017;17(1):17.","journal-title":"BMC Health Serv Res"},{"issue":"Supplement_2","key":"1574_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/heapol\/czz107","volume":"34","author":"A Koduah","year":"2019","unstructured":"Koduah A, Asare BA, Gavor E, Gyansa-Lutterodt M, Andrews Annan E, Ofei FW. Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana. Health Policy Plan. 2019;34(Supplement_2):104\u201320.","journal-title":"Health Policy Plan"},{"key":"1574_CR31","unstructured":"WHO. Measuring Transparency in Medicines Registration, Selection, and Procurement: Four Country Assessment Studies. Geneva: World Health Organisation; 2006. [Report]. https:\/\/www.rhsupplies.org\/uploads\/tx_rhscpublications\/WHO_Transparency_Laos%2C%20Phil%2C%20Thai%2C%20Malaysia_2006.pdf. Accessed 15 Aug 2022."},{"key":"1574_CR32","unstructured":"WHO Prequalification of Medicines. https:\/\/extranet.who.int\/prequal\/. Accessed 15 Aug 2022."},{"issue":"6","key":"1574_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.rbmo.2021.02.014","volume":"42","author":"M Hennessy","year":"2021","unstructured":"Hennessy M, Dennehy R, Meaney S, Linehan L, Devane D, Rice R, et al. Clinical practice guidelines for recurrent miscarriage in high-income countries: a systematic review. Reprod Biomed Online. 2021;42(6):1146\u201371.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"1574_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/humupd\/dmaa026","volume":"26","author":"LE O'Shea","year":"2020","unstructured":"O\u2019Shea LE, Hawkins JE, Lord J, Schmidt-Hansen M, Hasler E, Cameron S, et al. Access to and sustainability of abortion services: a systematic review and meta-analysis for the National Institute of Health and Care Excellence-new clinical guidelines for England. Hum Reprod Update. 2020;26(6):886\u2013903.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1574_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12889-017-4764-z","volume":"17","author":"C Glenton","year":"2017","unstructured":"Glenton C, Sorhaindo AM, Ganatra B, Lewin S. Implementation considerations when expanding health worker roles to include safe abortion care: a five-country case study synthesis. BMC Public Health. 2017;17(1):730.","journal-title":"BMC Public Health"},{"key":"1574_CR36","unstructured":"Ashford L, Sedgh G, Singh S. Making abortion services accessible in the wake of legal reforms. Issues Brief (Alan Guttmacher Inst). 2012;1:1\u20134. https:\/\/www.guttmacher.org\/sites\/default\/files\/report_pdf\/fb-abortion-services-laws_0.pdf. Accessed 24 Aug 2022."},{"key":"1574_CR37","unstructured":"Sundari Ravindran TK, Balasubramanian P, Bhate-Deosthali P. Availability of Safe Abortion Services and the Perspectives of Actors on the Right to Safe Abortion in the States of Bihar and Tamil Nadu, India. Gujarat, India: Common Health; 2018. [Report]. https:\/\/arrow.org.my\/wp-content\/uploads\/2019\/07\/India_Final-baseline-report.pdf. Accessed 28 Jul 2022."},{"issue":"2","key":"1574_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1363\/3709205","volume":"37","author":"AC Hwang","year":"2005","unstructured":"Hwang AC, Koyama A, Taylor D, Henderson JT, Miller S. Advanced practice clinicians\u2019 interest in providing medical abortion: results of a California survey. Perspect Sex Reprod Health. 2005;37(2):92\u20137.","journal-title":"Perspect Sex Reprod Health"},{"key":"1574_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12889-015-1502-2","volume":"15","author":"U Rehnstr\u00f6m Loi","year":"2015","unstructured":"Rehnstr\u00f6m Loi U, Gemzell-Danielsson K, Faxelid E, Klingberg-Allvin M. Health care providers\u2019 perceptions of and attitudes towards induced abortions in sub-Saharan Africa and Southeast Asia: a systematic literature review of qualitative and quantitative data. BMC Public Health. 2015;15:139.","journal-title":"BMC Public Health"},{"key":"1574_CR40","unstructured":"WHO. WHO Global EML. 2021. https:\/\/global.essentialmeds.org\/dashboard\/countries. Accessed 5 Aug 2022."},{"key":"1574_CR41","unstructured":"WHO. The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2011 (including the 17th WHO Model List of Essential). Geneva: World Health Organisation; 2011. [Report] https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists. Accessed 28 Jul 2022."},{"key":"1574_CR42","doi-asserted-by":"crossref","unstructured":"Singh S, Remez L, Sedgh G, Kwok L, Onda T. Abortion worldwide 2017: uneven progress and unequal access. New York: Guttmacher Institute, 2018 [Report]. https:\/\/www.guttmacher.org\/report\/abortion-worldwide-2017 Accessed 28 Jul 2022.","DOI":"10.1363\/2018.29199"},{"key":"1574_CR43","unstructured":"UNFPA Supplies Partnership 2021\u20132030. 2022. https:\/\/www.unfpa.org\/sites\/default\/files\/pub-pdf\/Welcome_to_the_UNFPA_Supplies_Partnership_2021-2030.pdf Accessed 28 Jul 2022."},{"issue":"10","key":"1574_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258624","volume":"16","author":"G Sharma","year":"2021","unstructured":"Sharma G, Molla YB, Budhathoki SS, Shibeshi M, Tariku A, Dhungana A, et al. Analysis of maternal and newborn training curricula and approaches to inform future trainings for routine care, basic and comprehensive emergency obstetric and newborn care in the low- and middle-income countries: lessons from Ethiopia and Nepal. PLoS ONE. 2021;16(10): e0258624.","journal-title":"PLoS ONE"},{"key":"1574_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1478-4491-7-2","volume":"7","author":"PA Gaye","year":"2009","unstructured":"Gaye PA, Nelson D. Effective scale-up: avoiding the same old traps. Hum Resour Health. 2009;7:2.","journal-title":"Hum Resour Health"},{"key":"1574_CR46","unstructured":"Hossain A, Maddow-Zimet J, Ingerick M, Bhuiyan U, Vlasshoff M, Singh S. Access to and Quality of Menstrual Regulation Services and Postabortion Care in Bangladesh, 2014. Guttmacher Institute; New York; 2017. [Report]. https:\/\/www.guttmacher.org\/report\/menstrual-regulation-postabortion-care-bangladesh Accessed 28 Jul 2022."},{"issue":"3","key":"1574_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/20786190.2017.1396790","volume":"60","author":"F Haffejee","year":"2018","unstructured":"Haffejee F, O\u2019Connor L, Govender N, Reddy P, Nokuthula Sibiya M, Ghuman S, et al. Factors associated with unintended pregnancy among women attending a public health facility in KwaZulu-Natal, South Africa. South Afr Fam Pract. 2018;60(3):79\u201383.","journal-title":"South Afr Fam Pract"},{"issue":"2","key":"1574_CR48","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1017\/S0021932013000461","volume":"46","author":"S Thapa","year":"2014","unstructured":"Thapa S, Sharma SK, Khatiwada N. Women\u2019s knowledge of abortion law and availability of services in Nepal. J Biosoc Sci. 2014;46(2):266\u201377.","journal-title":"J Biosoc Sci"},{"issue":"9","key":"1574_CR49","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1471-0528.2005.00697.x","volume":"112","author":"R Jewkes","year":"2005","unstructured":"Jewkes R, Gumede T, Westaway M, Dickson K, Brown H, Rees H. Why are women still aborting outside designated facilities in metropolitan South Africa? BJOG. 2005;112(9):1236\u201342.","journal-title":"BJOG"},{"issue":"10","key":"1574_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223385","volume":"14","author":"RB Khatri","year":"2019","unstructured":"Khatri RB, Poudel S, Ghimire PR. Factors associated with unsafe abortion practices in Nepal: pooled analysis of the 2011 and 2016 Nepal Demographic and Health Surveys. PLoS ONE. 2019;14(10): e0223385.","journal-title":"PLoS ONE"},{"issue":"1","key":"1574_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/sifp.12049","volume":"49","author":"K Footman","year":"2018","unstructured":"Footman K, Keenan K, Reiss K, Reichwein B, Biswas P, Church K. Medical abortion provision by pharmacies and drug sellers in low- and middle-income countries: a systematic review. Stud Fam Plann. 2018;49(1):57\u201370.","journal-title":"Stud Fam Plann"},{"issue":"5","key":"1574_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034670","volume":"10","author":"M Stillman","year":"2020","unstructured":"Stillman M, Owolabi O, Fatusi AO, Akinyemi AI, Berry AL, Erinfolami TP, Olagunju OS, V\u00e4is\u00e4nen H, Bankole A. Women\u2019s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria. BMJ Open. 2020;10(5): e034670.","journal-title":"BMJ Open"}],"updated-by":[{"DOI":"10.1186\/s12978-023-01691-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000}}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-023-01574-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-023-01574-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-023-01574-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T15:03:40Z","timestamp":1698332620000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-023-01574-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":52,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1186\/s12978-023-01574-3","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"25 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12978-023-01691-z","URL":"https:\/\/doi.org\/10.1186\/s12978-023-01691-z","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not applicable as these country assessments were led by the ministries of health as programme assessments and not conducted as research activities. The information collected during the desk review is publicly available data and the key informants all participated within their official capacity and were selected by the ministries of health. Verbal informed consent to participate in the assessment was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}